Fermenta Biotech Limited (BOM:506414)
India · Delayed Price · Currency is INR 312.80
+1.45 (0.47%)
At close: Feb 12, 2026
Fermenta Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 768.62 | -230.6 | -510.75 | 154.47 | 455.07 |
Depreciation & Amortization | 240.87 | 244.55 | 277.83 | 248.84 | 196.52 |
Other Amortization | 1.31 | 2.65 | 4.64 | 6.78 | 6.57 |
Loss (Gain) From Sale of Assets | 70.17 | 381.26 | 447.58 | 0.27 | 1.6 |
Stock-Based Compensation | - | 1.91 | -10.19 | 26.97 | 59.21 |
Provision & Write-off of Bad Debts | 11.72 | 8.56 | 53 | 14.47 | 20.99 |
Other Operating Activities | 141.34 | 318.1 | 449.45 | 156.41 | 37.24 |
Change in Accounts Receivable | -341.58 | -339.48 | 353.07 | -170.17 | 64.61 |
Change in Inventory | -362.67 | 427.56 | 99.31 | 27.94 | -191.66 |
Change in Accounts Payable | 137.9 | 243.19 | -152.71 | 31.3 | -75.25 |
Change in Other Net Operating Assets | -258.66 | -4.23 | 149.85 | -62.85 | 51.09 |
Operating Cash Flow | 409.02 | 1,053 | 1,161 | 434.41 | 625.97 |
Operating Cash Flow Growth | -61.17% | -9.27% | 167.28% | -30.60% | 81.65% |
Capital Expenditures | -221.33 | -192.07 | -404.89 | -371.28 | -552.71 |
Sale of Property, Plant & Equipment | 192.51 | 0.65 | 0.46 | 0.91 | 0.13 |
Cash Acquisitions | - | - | - | - | -94.39 |
Investment in Securities | -50.97 | 40.34 | -163.9 | 38.81 | 18.03 |
Other Investing Activities | 78.2 | -3.9 | 14.25 | 71.19 | 213.44 |
Investing Cash Flow | -1.6 | -154.97 | -554.09 | -260.38 | -415.5 |
Short-Term Debt Issued | - | - | 22.91 | 5.97 | 35.85 |
Long-Term Debt Issued | - | 30.54 | 363.08 | 243.05 | 291.65 |
Total Debt Issued | - | 30.54 | 386 | 249.02 | 327.5 |
Short-Term Debt Repaid | -24.8 | -218.15 | - | - | - |
Long-Term Debt Repaid | -347.94 | -518.17 | -552.37 | -225.96 | -163.59 |
Total Debt Repaid | -372.74 | -736.32 | -552.37 | -225.96 | -163.59 |
Net Debt Issued (Repaid) | -372.74 | -705.79 | -166.37 | 23.06 | 163.91 |
Issuance of Common Stock | 24.67 | - | - | - | - |
Common Dividends Paid | -36.12 | -36.09 | -42 | -72.12 | - |
Other Financing Activities | -124.47 | -166.64 | -205.43 | -166.73 | -175.34 |
Financing Cash Flow | -508.66 | -908.52 | -413.8 | -215.78 | -11.43 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0.49 | - | 6.12 |
Net Cash Flow | -101.23 | -10.03 | 193.69 | -41.75 | 205.16 |
Free Cash Flow | 187.69 | 861.39 | 756.19 | 63.13 | 73.26 |
Free Cash Flow Growth | -78.21% | 13.91% | 1097.83% | -13.83% | - |
Free Cash Flow Margin | 4.00% | 25.66% | 21.61% | 1.58% | 1.94% |
Free Cash Flow Per Share | 6.43 | 29.83 | 26.20 | 2.18 | 2.53 |
Cash Interest Paid | 124.47 | 166.64 | 205.43 | 166.73 | 175.34 |
Cash Income Tax Paid | 27.71 | -10.18 | -32.08 | 93.08 | 135.22 |
Levered Free Cash Flow | 10.22 | 158.24 | 528.43 | -163.2 | 110.82 |
Unlevered Free Cash Flow | 98.92 | 264.78 | 658.32 | -61.52 | 208.76 |
Change in Working Capital | -825.02 | 327.04 | 449.52 | -173.78 | -151.22 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.